Annual report pursuant to Section 13 and 15(d)

Note 21 - Segment Information: Schedule of Segment Information (Tables)

v3.21.1
Note 21 - Segment Information: Schedule of Segment Information (Tables)
12 Months Ended
Dec. 31, 2020
Tables/Schedules  
Schedule of Segment Information

 

 

 

Cannabis and

Medical

Marijuana

Segment

 

Facilities

Operations

Related

 

Corporate,

Other, and

Eliminations

 

Consolidated

2020

 

 

 

 

 

 

 

 

Net sales

$

47,707

$

4,778,249

$

-

$

4,825,956

Operating income (loss)

 

(13,258)

 

(231,162)

 

(829,684)

 

(1,074,104)

Interest income

 

-

 

-

 

92,571

 

92,571

Interest expense

 

-

 

34,711

 

584

 

35,295

Total assets

 

1,042,553

 

1,874,519

 

1,524,023

 

4,441,095

Property additions

 

-

 

126,396

 

7,593

 

133,989

Fixed asset depreciation and amortization

 

-

 

20,553

 

7,103

 

27,656

 

 

 

 

 

 

 

 

 

2019

 

 

 

 

 

 

 

 

Net sales

$

158,614

$

4,167,858

$

-

$

4,326,472

Operating income (loss)

 

(796,232)

 

74,128

 

(1,023,839)

 

(1,745,943)

Interest income

 

19,745

 

10

 

88,358

 

108,113

Interest expense

 

-

 

26,921

 

(4,325)

 

22,596

Total assets

 

1,484,877

 

1,646,867

 

1,834,833

 

4,966,577

Property additions

 

-

 

11,766

 

-

 

11,766

Fixed asset depreciation and amortization

 

-

 

11,333

 

11,780

 

23,113